医疗保健领域量子运算市场－全球产业规模、份额、趋势、机会和预测：按组件、技术、应用、地区和竞争格局划分，2021-2031年

全球医疗保健量子运算市场预计将从 2025 年的 1,389.4 亿美元成长到 2031 年的 1.17369 兆美元，复合年增长率将达到 42.71%。

在该领域，动态原理，特别是量子纠缠和量子迭加原理，被应用于处理复杂的生物和化学数据，其速度比传统超级电脑快得多。市场的主要驱动因素是迫切需要加速药物研发进程，以及对高精度基因组分析日益增长的需求，以促进个人化医疗。满足这些需求需要先进的模拟能力，能够以传统运算方法无法企及的精度模拟分子间交互作用，进而显着降低研发成本。

然而，在技术成熟度方面仍存在着许多挑战，尤其是在杂讯环境下维持量子位元相干性和控制错误率的难度。这种硬体不稳定性目前限制了实际应用的扩充性，因此需要製定谨慎的整合策略。皮斯托亚联盟的报告显示，到2025年，约有18%的生命科学机构计划在其实验室中使用量子计算。儘管这项技术具有变革性的潜力，但这一数字凸显了仍然存在的巨大技术挑战。

市场驱动因素

全球医疗保健领域量子运算市场的最大驱动力是分子模拟和药物发现的加速。传统计算方法无法以必要的精度模拟分子间相互作用的复杂性，这成为药物研发的瓶颈。量子演算法透过在原子层面模拟化学过程来克服这项挑战，从而显着减少识别潜在候选药物所需的时间和资金。认识到这项潜力，主要企业正在投入大量资源。例如，根据2024年5月发布的题为「Novo Holdings向量子技术Start-Ups生态系统投入14亿丹麦克朗」的新闻稿，该公司已专门拨款1.88亿欧元用于开发旨在直接应用于生命科学领域的量子技术。

推动市场成长的第二个关键因素是公共和私人投资的增加。这些投资为实验技术的成熟奠定了必要的基础。各国政府和私人机构正在建立专门的中心，以解决硬体不稳定问题，并扩大量子技术在诊断和治疗领域的实际应用。例如，英国政府在2024年7月宣布“政府将投资1亿英镑建立五个量子研究中心”，详细说明了这笔1亿英镑的投资将用于建立专门从事医疗感测和医疗保健的新中心。同样，在2024年12月，惠康基金会（Wellcome Leap）的「量子生物」（Quantum for Bio）计画也保持了强劲势头，为在人类健康领域展现量子优势的计划提供高达4000万美元的研究经费。

市场挑战

全球医疗保健量子运算市场的主要障碍在于硬体稳定性的技术成熟度不足，尤其是在应对高错误率和维持量子位元相干性方面面临许多挑战。在基因组学和製药领域，分子模拟对于患者安全和药物疗效至关重要，需要绝对的精度，而目前「噪声中等规模量子（NISQ）」处理器往往无法维持复杂计算所需的状态保真度。这种不稳定性使得量子系统无法可靠地用于监管层级的数据处理，迫使生命科学公司只能将其应用限制在实验性试验计画中，而无法将这项技术整合到关键的研发流程中。

雪上加霜的是，解决复杂物理问题和加速开发容错硬体所需的熟练工程师严重短缺。根据量子经济发展联盟（QED-C）预测，到2025年，全球量子产业将面临严重的人才短缺，届时将有超过7,400个技术职缺。这种熟练人才的短缺将直接延缓降低错误率所需的技术突破，阻碍量子解决方案在医疗保健领域的商业性可行性，并抑制整体市场扩张。

市场趋势

量子运算与人工智慧 (AI) 和机器学习的融合正在重塑市场格局，突破了传统 AI 在分子模拟领域的运算极限。这一趋势利用大规模定量模型和量子思维演算法产生精确的 AI 训练数据，从而以前所未有的精度模拟复杂的生物系统。透过将基于物理的量子模拟与加速计算相结合，研究人员可以模拟以前无法建模的酶活性位点和催化剂。正如 2024 年 7 月的新闻稿《SandboxAQ 支持下一代 AI 驱动化学的实现》中所述，SandboxAQ 与 NVIDIA 的联合研究已使量子化学计算速度比传统的基于 CPU 的方法快 80 倍，显着缩短了药物发现过程。

此外，采用混合量子-经典运算架构正逐渐成为克服目前杂讯中等规模量子（NISQ）硬体限制的关键策略。在这种模式下，製药公司利用量子处理器解决特定的运算密集型子问题，例如分子折迭，同时将剩余的工作负载卸载到经典超级电脑。这种方法使企业能够即时从量子系统开发中获益，而无需等待完全容错的机器。例如，在2024年6月发布的题为「Moderna和IBM展示用于mRNA二级结构预测的量子-经典方法」的公告中，IBM和Moderna展示了一种混合工作流程，该流程使用80个量子位元成功模拟了多达60个碱基对的mRNA二级结构。这是一个创纪录的规模，并展示了混合系统在复杂药物设计中日益增长的效用。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：医疗保健领域量子运算的全球市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 按组件（硬体、软体、服务）
  • 透过技术（超导性位元、囚禁离子、量子退火等）
  • 按应用领域（药物发现/开发、医学诊断、基因组学/精准医学、放射治疗、风险分析等）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美医疗保健领域量子运算市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲医疗保健领域量子运算市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区医疗保健领域量子运算市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲医疗保健领域量子运算市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲医疗保健领域量子运算市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球医疗保健量子运算市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• IBM Corporation
• Google LLC
• Microsoft Corporation
• Intel Corporation
• Honeywell International Inc.
• D-Wave Systems Inc.
• Amazon.com, Inc.
• IonQ, Inc.
• Rigetti Computing, Inc.
• Accenture plc

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Quantum Computing in Healthcare Market is projected to expand from USD 138.94 Billion in 2025 to USD 1173.69 Billion by 2031, achieving a CAGR of 42.71%. This field involves applying quantum mechanical principles, specifically entanglement and superposition, to process intricate biological and chemical data at speeds exponentially exceeding those of classical supercomputers. The market is primarily driven by the urgent need to expedite pharmaceutical drug discovery pipelines and the growing demand for high-precision genomic analysis to facilitate personalized medicine. These requirements necessitate advanced simulation capabilities capable of modeling molecular interactions with an accuracy that traditional computational methods cannot match, thereby significantly lowering research and development costs.

However, the market faces substantial obstacles regarding technical maturity, particularly the difficulty of maintaining qubit coherence and managing error rates within noisy environments. This hardware instability currently restricts the scalability of practical applications, necessitating a cautious integration strategy. The experimental nature of the technology is highlighted by the Pistoia Alliance, which reported that in 2025, approximately 18% of life sciences organizations anticipated utilizing quantum computing in their laboratories, a figure that underscores the engineering hurdles that persist despite the technology's transformative potential.

Market Driver

The most significant driver for the Global Quantum Computing in Healthcare Market is the ability to accelerate molecular simulation and drug discovery. Traditional computational methods frequently fail to model the complexity of molecular interactions with the necessary precision, creating bottlenecks in pharmaceutical R&D. Quantum algorithms overcome this by simulating chemical processes at the atomic level, significantly reducing both the time and capital required to identify viable drug candidates. This potential has prompted major industry players to allocate substantial resources; for instance, according to a May 2024 press release titled 'Novo Holdings Commits DKK 1.4 Billion to Quantum Technology Start-Up Ecosystem,' Novo Holdings allocated EUR 188 million specifically to advance quantum technologies with direct life sciences applications.

A second critical factor propelling market growth is the rise in public and private investments, which provide the essential infrastructure for these experimental technologies to mature. Governments and private entities are establishing dedicated hubs to address hardware instability and scale practical use cases in diagnostics and treatment. For example, the UK Government announcement 'Government invests £100m in five quantum research hubs' in July 2024 detailed a £100 million investment to establish new centers, including those focused on medical sensing and healthcare. Similarly, in December 2024, Wellcome Leap's Quantum for Bio program continued its momentum by advancing projects eligible for up to $40 million in research funding to demonstrate quantum advantage in human health.

Market Challenge

The primary impediment to the Global Quantum Computing in Healthcare Market is the lack of technical maturity concerning hardware stability, specifically the challenge of managing high error rates and maintaining qubit coherence. In the genomic and pharmaceutical sectors, where molecular simulations demand absolute precision for patient safety and drug efficacy, current "Noisy Intermediate-Scale Quantum" (NISQ) processors often fail to maintain the state fidelity required for complex calculations. This instability makes quantum systems unreliable for regulatory-grade data processing, forcing life sciences organizations to restrict their engagement to experimental pilot programs rather than integrating the technology into critical R&D workflows.

Compounding this challenge is a severe shortage of the specialized engineering talent needed to solve these intricate physics problems and accelerate the development of fault-tolerant hardware. According to the Quantum Economic Development Consortium (QED-C), the global quantum industry faced a critical workforce gap in 2025, with more than 7,400 unfilled technical job openings. This scarcity of skilled human capital directly slows the engineering breakthroughs required to reduce error rates, thereby delaying the commercial viability of quantum solutions for healthcare applications and stifling overall market expansion.

Market Trends

The integration of Quantum Computing with Artificial Intelligence and Machine Learning is reshaping the market by transcending the computational limits of classical AI in molecular simulation. This trend involves using large quantitative models and quantum-inspired algorithms to generate precise training data for AI, enabling the modeling of complex biological systems with unprecedented accuracy. By combining physics-based quantum simulations with accelerated computing, researchers can simulate enzyme active sites and catalysts that were previously impossible to model. As noted in the 'SandboxAQ Helps Unlock the Next Generation of AI-Driven Chemistry' press release from July 2024, SandboxAQ's collaboration with NVIDIA achieved an 80x speedup in quantum chemistry calculations compared to traditional CPU-based methods, significantly shortening drug discovery timelines.

Additionally, the adoption of Hybrid Quantum-Classical Computing Architectures is emerging as a critical strategy to bypass the limitations of current noisy intermediate-scale quantum (NISQ) hardware. In this model, pharmaceutical companies utilize quantum processors to solve specific, computationally intensive sub-problems-such as molecular folding-while offloading remaining workloads to classical supercomputers. This approach allows organizations to derive immediate value from developing quantum systems without waiting for fully fault-tolerant machines. For instance, in the June 2024 announcement 'Moderna and IBM Demonstrate Quantum-Classical Approach for mRNA Secondary Structure Prediction,' IBM and Moderna revealed that their hybrid workflow successfully simulated mRNA secondary structures of up to 60 nucleotides using 80 qubits, a record-setting scale that demonstrates the growing utility of hybrid systems for complex therapeutic design.

Key Market Players

• IBM Corporation
• Google LLC
• Microsoft Corporation
• Intel Corporation
• Honeywell International Inc.
• D-Wave Systems Inc.
• Amazon.com, Inc.
• IonQ, Inc.
• Rigetti Computing, Inc.
• Accenture plc

Report Scope

In this report, the Global Quantum Computing in Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Quantum Computing in Healthcare Market, By Component

• Hardware
• Software
• Services

Quantum Computing in Healthcare Market, By Technology

• Superconducting Qubits
• Trapped Ions
• Quantum Annealing
• Others

Quantum Computing in Healthcare Market, By Application

• Drug Discovery & Development
• Medical Diagnostics
• Genomics & Precision Medicine
• Radiotherapy
• Risk Analysis
• Others

Quantum Computing in Healthcare Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Quantum Computing in Healthcare Market.

Available Customizations:

Global Quantum Computing in Healthcare Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Quantum Computing in Healthcare Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Component (Hardware, Software, Services)
  • 5.2.2. By Technology (Superconducting Qubits, Trapped Ions, Quantum Annealing, Others)
  • 5.2.3. By Application (Drug Discovery & Development, Medical Diagnostics, Genomics & Precision Medicine, Radiotherapy, Risk Analysis, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Quantum Computing in Healthcare Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component
  • 6.2.2. By Technology
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Quantum Computing in Healthcare Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Component
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Quantum Computing in Healthcare Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Component
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Quantum Computing in Healthcare Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Component
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Application

7. Europe Quantum Computing in Healthcare Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component
  • 7.2.2. By Technology
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Quantum Computing in Healthcare Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Application
  • 7.3.2. France Quantum Computing in Healthcare Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Quantum Computing in Healthcare Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Quantum Computing in Healthcare Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Quantum Computing in Healthcare Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Application

8. Asia Pacific Quantum Computing in Healthcare Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component
  • 8.2.2. By Technology
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Quantum Computing in Healthcare Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Application
  • 8.3.2. India Quantum Computing in Healthcare Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Quantum Computing in Healthcare Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Quantum Computing in Healthcare Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Quantum Computing in Healthcare Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Application

9. Middle East & Africa Quantum Computing in Healthcare Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component
  • 9.2.2. By Technology
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Quantum Computing in Healthcare Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Quantum Computing in Healthcare Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Quantum Computing in Healthcare Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Application

10. South America Quantum Computing in Healthcare Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component
  • 10.2.2. By Technology
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Quantum Computing in Healthcare Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Quantum Computing in Healthcare Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Quantum Computing in Healthcare Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Quantum Computing in Healthcare Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. IBM Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Google LLC
• 15.3. Microsoft Corporation
• 15.4. Intel Corporation
• 15.5. Honeywell International Inc.
• 15.6. D-Wave Systems Inc.
• 15.7. Amazon.com, Inc.
• 15.8. IonQ, Inc.
• 15.9. Rigetti Computing, Inc.
• 15.10. Accenture plc

16. Strategic Recommendations

17. About Us & Disclaimer